FDA investigators issued a Form FDA 483 (FDA-483), Inspectional Observations. Key issues included failure to monitor critical sterilization temperatures, inadequate recording procedures for ...

The U.S. Food and Drug Administration has lifted a clinical hold on three cell therapies being developed by CARsgen ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Drug maker Cipla on Wednesday said the US health regulator has issued eight observations after inspecting its Bengaluru-based ...

Hagens Berman urges investors in Humacyte, Inc. (NASDAQ: HUMA) who suffered substantial losses to submit your losses now .

The FDA conducted an inspection at the manufacturing facility in Virgonagar from Nov. 7 to Nov. 13, according to an exchange ...

Raichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four ...

On Friday, BTIG reaffirmed its Buy rating and $10.00 stock price target for Humacyte (NASDAQ:HUMA) following the release of a Form 483 from the FDA. The form, which details findings from facility ...

Vijayawada: The Andhra Sugars Limited has undergone US FDA inspection at their aspirin manufacturing facility at ...

Philadelphia, Pennsylvania-- (Newsfile Corp. - October 29, 2024) - Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Humacyte, Inc. ("Humacyte" or the ...